Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population
Crossref DOI link: https://doi.org/10.1007/s00198-017-4072-6
Published Online: 2017-05-23
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keshishian, A.
Boytsov, N.
Burge, R.
Krohn, K.
Lombard, L.
Zhang, X.
Xie, L.
Baser, O.
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2017-05-23